Evaluation of the Efficacy of Diafert in Predicting Embryos' Potential to Develop to the Blastocyst Stage
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02788617. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Non-interventional, Multicenter, Clinical Study to Evaluate the Efficacy of the Diafert G-CSF ELISA as an Adjunct to Morphological Assessment in Predicting Embryos' Potential to Develop to the Blastocyst Stage
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This prospective study will evaluate the efficacy of Diafert as an adjunct to morphological assessment in predicting embryos' potential to develop to the blastocyst stage on Day 5.
Study identification
- NCT ID
- NCT02788617
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 24, 2016 (Actual)
- Primary completion
- Jan 30, 2017 (Actual)
- Completion
- Apr 4, 2017 (Actual)
- Last update posted
- Jul 31, 2017
2016 – 2017
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Huntington Reproductive Center | Encino | California | 91436 | — |
| Women's Medical Research Group | Clearwater | Florida | 33759 | — |
| InVia Fertility Specialists | Hoffman Estates | Illinois | 60169 | — |
| Institute for Reproductive Health | Cincinnati | Ohio | 45209 | — |
| Main Line Fertility Center | Bryn Mawr | Pennsylvania | 19010 | — |
| Dallas - Fort Worth Fertility Associates | Dallas | Texas | 75231 | — |
| Houston Fertility Institute | Houston | Texas | 77063 | — |
| Utah Fertiity Center | Pleasant Grove | Utah | 84062 | — |
| Reproductive Care Center | Sandy City | Utah | 84092 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02788617, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 31, 2017 · Synced Nov 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.